Hepatitis B and D

Viral liver infections can be very severe; hepatitis B and D are transmitted through sexual contact, blood, and from mother to fetus. Vaccination and screening are the cornerstones of prevention.

Our missions

  • To conduct epidemiological surveillance of hepatitis B and D

  • Enabling the adaptation of preventive measures

  • Informing healthcare professionals

Hepatitis B Mortality Data

A survey on mortality related to hepatitis B and C conducted in 2004–2005 among certifying physicians estimated that in 2001:

  • The number of deaths associated with HBV was 1,507 (95% CI: 640–2,373), corresponding to a mortality rate of 2.6 per 100,000 (95% CI: 1.4–4.5).

  • The number of deaths attributable to HBV was 1,327 (95% CI: 463–2,192), corresponding to a mortality rate of 2.2 per 100,000 (95% CI: 0.8–3.7).

  • The death rate was 2.5 times higher among men than among women, with a median age at death of 65 years.

  • The stage of the disease at the time of death was at least cirrhosis in 93% of cases and hepatocellular carcinoma on cirrhosis in 35% of cases.

An analysis of data from the Medical Information Systems Program (PMSI) estimated the number of deaths among patients with chronic hepatitis B at 4,965 during the 2004–2011 period, representing an overall mortality rate of 9.1%. Mortality was higher among men than among women (11.0% vs. 6.0%). More than 60% of deaths occurred among hospitalized patients with a complication.

article

6 September 2019

National estimate of mortality associated with and attributable to hepatitis C and hepatitis B in mainland France in 2001

article

6 September 2019

Prevalence, Morbidity, and Mortality Associated with Chronic Hepatitis B and C Among Hospitalized Patients in France, 2004–2011

GEODES

Track the trends in hepatitis B in France and in your region